BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1118 related articles for article (PubMed ID: 16115493)

  • 21. Comparison of lower esophageal sphincter manometrics and gastroesophageal reflux measured by 24-hour pH recording.
    Kraus BB; Wu WC; Castell DO
    Am J Gastroenterol; 1990 Jun; 85(6):692-6. PubMed ID: 2353688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical value of pharyngeal pH monitoring using a double-probe, triple-sensor catheter in patients with laryngopharyngeal reflux.
    Muderris T; Gokcan MK; Yorulmaz I
    Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):163-7. PubMed ID: 19221244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
    Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
    Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual site ambulatory pH monitoring: a probe across the lower esophageal sphincter does not induce gastroesophageal reflux.
    Decktor DL; Krawet SH; Rodriguez SL; Robinson M; Castell DO
    Am J Gastroenterol; 1996 Jun; 91(6):1162-6. PubMed ID: 8651164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of esophageal manometry in the management of the patients with gastro-esophageal reflux disease and Barrett's esophagus].
    Hoară P; Bîrlă R; Gîndea C; Constantin A; Panaitescu G; Iordan N; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(4):407-12. PubMed ID: 18780613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ineffective motility is not a marker for gastroesophageal reflux disease.
    Vinjirayer E; Gonzalez B; Brensinger C; Bracy N; Obelmejias R; Katzka DA; Metz DC
    Am J Gastroenterol; 2003 Apr; 98(4):771-6. PubMed ID: 12738454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of pH monitoring and esophageal manometry in the evaluation of results of surgical therapy for gastroesophageal reflux disease.
    Soyer T; Karnak I; Tanyel FC; Senocak ME; Ciftci AO; Büyükpamukçu N
    Eur J Pediatr Surg; 2007 Jun; 17(3):158-62. PubMed ID: 17638153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laryngopharyngeal reflux identified using a new catheter design: defining normal values and excluding artifacts.
    Maldonado A; Diederich L; Castell DO; Gideon RM; Katz PO
    Laryngoscope; 2003 Feb; 113(2):349-55. PubMed ID: 12567094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of esophageal manometry and gastroesophageal pH monitoring for responsiveness of reflux disease to medical therapy in children.
    Cucchiara S; Campanozzi A; Greco L; Franco MT; Emiliano M; Alfieri E; Calabrese F; Numeroso V
    Am J Gastroenterol; 1996 Apr; 91(4):680-5. PubMed ID: 8677928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring.
    Dobhan R; Castell DO
    Am J Gastroenterol; 1993 Jan; 88(1):25-9. PubMed ID: 8420269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manometric study of lower esophageal sphincter in children with primary acid gastroesophageal reflux and acid gastroesophageal reflux secondary to food allergy.
    Semeniuk J; Kaczmarski M; Uścinowicz M
    Adv Med Sci; 2008; 53(2):283-92. PubMed ID: 18842562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters.
    Velanovich V; Karmy-Jones R
    Am Surg; 1998 Jul; 64(7):649-53. PubMed ID: 9655276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
    Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
    Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring.
    Vaezi MF; Schroeder PL; Richter JE
    Am J Gastroenterol; 1997 May; 92(5):825-9. PubMed ID: 9149194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flexible laryngoscopy-guided pharyngeal pH monitoring in infants.
    Ulualp SO; Rodriguez S; Holmes-Wright CN
    Laryngoscope; 2007 Apr; 117(4):577-80. PubMed ID: 17415124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal dysmotility as an important co-factor in extraesophageal manifestations of gastroesophageal reflux.
    Knight RE; Wells JR; Parrish RS
    Laryngoscope; 2000 Sep; 110(9):1462-6. PubMed ID: 10983943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease.
    Lee J; Anggiansah A; Anggiansah R; Young A; Wong T; Fox M
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1392-8. PubMed ID: 17936081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Esophageal manometry in gastroesophageal reflux disease. Lower esophageal sphincter incompetence or esophageal dismotility?].
    Valdovinos Díaz MA; Flores C; Facha MT; Koller Lucio J
    Rev Gastroenterol Mex; 1999; 64(1):16-8. PubMed ID: 10532117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esophageal function studies in the management of gastroesophageal reflux disease.
    Incarbone R; Bonavina L; Reitano M; Peracchia A
    Int J Surg Investig; 1999; 1(4):351-6. PubMed ID: 12774461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.